Oligoribonuclease regulation of cyclic-di-GMP signaling and chronic biofilm infections
环二 GMP 信号传导和慢性生物膜感染的寡核糖核酸酶调节
基本信息
- 批准号:10620734
- 负责人:
- 金额:$ 58.02万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-06-01 至 2025-05-31
- 项目状态:未结题
- 来源:
- 关键词:5&apos-exoribonucleaseActive SitesAffectBacteriaBacterial InfectionsBacterial PhysiologyBiochemicalBiological AssayBypassCatalysisCatalytic DomainCathetersCell Culture TechniquesCell physiologyChronicComplementComplexCuesDataDefectDegradation PathwayDinucleoside PhosphatesEnzymesExcisionExoribonucleasesFamilyFeedbackGammaproteobacteriaGene ExpressionGenesGeneticGenetic TranscriptionGoalsGrantHydrolysisInfectionInterdisciplinary StudyKidneyKnowledgeLengthMicrobial BiofilmsMolecularNucleotidesOligonucleotidesOligoribonucleotidesOperonOrganismPathway interactionsPeriodicityPhenotypePhosphodiesterase IPhysiologicalProcessPropertyProteinsPseudomonas aeruginosaPseudomonas aeruginosa infectionPublicationsRNARNA DegradationRecyclingRegulationRibonucleasesRoleSecond Messenger SystemsSignal TransductionSignal Transduction PathwaySignaling MoleculeStructureStructure-Activity RelationshipTestingTimeType III Secretion System PathwayUp-RegulationVirulenceX-Ray Crystallographycatheter associated UTIchronic infectiondetection methoddiguanylate cyclaseendonucleasegene functionhuman pathogenin vivomembermouse modelmutantnanooligoribonucleasepathogenic bacteriaphosphoric diester hydrolasepreferencepyochelinresponsetripolyphosphate
项目摘要
ABSTRACT
!
Bacteria use cyclic-di-GMP (c-di-GMP) as a secondary signaling molecule to relay environmental cues to
phenotypic changes, including biofilm formation and virulence. C-di-GMP is degraded in two sequential
enzymatic steps: 1. Linearization to pGpG by phosphodiesterase-A (PDE-A) and 2. Hydrolysis of pGpG to
GMP by PDE-B. While PDE-A enzymes have been studied more extensively, we only recently identified
oligoribonuclase (Orn) as the primary PDE-B in Pseudomonas aeruginosa. A P. aeruginosa ∆orn mutant
has elevated levels of pGpG and c-di-GMP, resulting in hyperbiofilm formation. Notably, our preliminary
data indicate that the ∆orn mutant is also unable to disseminate in a murine model of catheter-associated
urinary tract infection (CAUTI). However, the underlying molecular mechanisms remain enigmatic. Orn is
described as a 3' to 5' exoribonuclease that is thought to cleave short oligonucleotides from 2-7 residues
in length, completing RNA degradation. Orn is unique amongst exoribonucleases since it is the only
member known to be essential in many gammaproteobacteria. Based on our data, Orn appears to function
at the intersection between RNA degradation and c-di-GMP signaling, but how an enzyme regulates both
dinucleotide signaling and global RNA pools is poorly understood. To bridge this fundamental knowledge
gap regarding Orn's unique function, we developed an interdisciplinary research plan. We hypothesize
that Orn's enzymatic and physiological function deviates from the popular view that Orn acts as rather
unspecific nano-RNase. Instead, based on new structures of Orn in complex with pGpG that reveal a
constrained catalytic site optimized for dinucleotide substrates, we propose that Orn functions primarily as
an endonuclease for dinucleotides. Further preliminary data demonstrate that organisms that do not
encode orn have additional genes that function as PDE-B. Our previous publications and preliminary data
form the scientific premise underlying our overarching hypothesis that PDE-Bs are dinucleotidases that
regulate c-di-GMP signaling and chronic infection. To test our hypothesis, we will complete the following
aims: 1. Characterize the molecular basis for substrate recognition and catalysis by PDE-Bs; 2. Elucidate
Orn substrate preferences and effects on oligonucleotide pools; and 3. Determine the pathways regulated
by Orn during chronic P. aeruginosa catheter-associated urinary tract infections. Results from our
proposed studies will reveal the structural basis for PDE-Bs preference for dinucleotides, provide
biochemical evidence that PDE-Bs are dinucleotidases, reveal the impact of loss of PDE-Bs on the
accumulation of diucleotide and oligonucleotide pools, and uncover altered regulation leading to defects
during chronic infections. The impact of the grant is to understand the intersection of RNA degradation and
cyclic dinucleotide signaling and to assign a defined function for PDE-Bs that is consistent with their
observed physiological roles in signaling and infection.
摘要
!
细菌使用环二GMP(c-di-GMP)作为二级信号分子,将环境线索传递给
表型变化,包括生物膜形成和毒力。C-di-GMP以两种顺序降解
酶促步骤:1.通过磷酸二酯酶-A(PDE-A)线性化pGpG,2. pGpG水解成
PDE-B的GMP。虽然PDE-A酶已经被更广泛地研究,但我们最近才发现,
寡核糖核酸酶(Orn)作为铜绿假单胞菌中的主要PDE-B。铜绿假单胞菌突变体
pGpG和c-di-GMP水平升高,导致超生物膜形成。值得注意的是,我们的初步
数据表明,在导管相关性肿瘤的鼠模型中,
泌尿道感染(CITTI)。然而,潜在的分子机制仍然是谜。Orn是
被描述为3'至5'核糖核酸外切酶,被认为从2-7个残基切割短寡核苷酸
长度,完成RNA降解。ORN在核糖核酸外切酶中是独特的,因为它是唯一的
已知在许多γ-变形菌中是必需的成员。根据我们的数据,奥恩似乎
在RNA降解和c-di-GMP信号传导之间的交叉点,但酶如何调节两者
二核苷酸信号传导和全局RNA库的理解很少。为了将这些基本知识
关于奥恩的独特功能的差距,我们制定了一个跨学科的研究计划。我们假设
Orn的酶和生理功能偏离了流行的观点,
非特异性纳米RNA酶。相反,基于Orn与pGpG复合的新结构,揭示了一种新的
限制催化位点优化二核苷酸底物,我们建议Orn的功能主要是
二核苷酸的核酸内切酶。进一步的初步数据表明,
编码ORN具有作为PDE-B起作用另外的基因。我们以前的出版物和初步数据
形成了我们总体假设的科学前提,即PDE-B是二核苷酸酶,
调节c-di-GMP信号传导和慢性感染。为了验证我们的假设,我们将完成以下操作
目标:1.表征PDE-Bs对底物识别和催化的分子基础; 2.阐明
Orn底物偏好和对寡核苷酸池的影响;和3.确定调节的途径
奥恩在慢性铜绿假单胞菌导管相关尿路感染期间使用。源自我们的
提出的研究将揭示PDE-B对二核苷酸的偏好的结构基础,
PDE-Bs是二核苷酸酶的生物化学证据,揭示了PDE-Bs的丢失对
二核苷酸和寡核苷酸池的积累,并揭示导致缺陷的调节改变
在慢性感染中。该基金的影响是了解RNA降解和
环二核苷酸信号传导,并为PDE-B分配与其功能一致的定义功能。
观察信号和感染的生理作用。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
NrnA is a 5'-3' exonuclease that processes short RNA substrates in vivo and in vitro.
- DOI:10.1093/nar/gkac1091
- 发表时间:2022-11-28
- 期刊:
- 影响因子:14.9
- 作者:Weiss, Cordelia A.;Myers, Tanner M.;Wu, Chih Hao;Jenkins, Conor;Sondermann, Holger;Lee, Vincent T.;Winkler, Wade C.
- 通讯作者:Winkler, Wade C.
Bacillus subtilis NrnB is expressed during sporulation and acts as a unique 3'-5' exonuclease.
- DOI:10.1093/nar/gkad662
- 发表时间:2023-10-13
- 期刊:
- 影响因子:14.9
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
VINCENT T LEE其他文献
VINCENT T LEE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('VINCENT T LEE', 18)}}的其他基金
Characterization of cyclic-GMP-cAMP regulation in Vibrio cholerae
霍乱弧菌中环 GMP-cAMP 调节的特征
- 批准号:
10614436 - 财政年份:2022
- 资助金额:
$ 58.02万 - 项目类别:
Characterization of cyclic-GMP-cAMP regulation in Vibrio cholerae
霍乱弧菌中环 GMP-cAMP 调节的特征
- 批准号:
10371521 - 财政年份:2022
- 资助金额:
$ 58.02万 - 项目类别:
Oligoribonuclease regulation of cyclic-di-GMP signaling and chronic biofilm infections
环二 GMP 信号传导和慢性生物膜感染的寡核糖核酸酶调节
- 批准号:
10163122 - 财政年份:2019
- 资助金额:
$ 58.02万 - 项目类别:
Oligoribonuclease regulation of cyclic-di-GMP signaling and chronic biofilm infections
环二 GMP 信号传导和慢性生物膜感染的寡核糖核酸酶调节
- 批准号:
10410509 - 财政年份:2019
- 资助金额:
$ 58.02万 - 项目类别:
High-throughput assay for protein-ligand interaction
蛋白质-配体相互作用的高通量测定
- 批准号:
8176077 - 财政年份:2011
- 资助金额:
$ 58.02万 - 项目类别:
High-throughput assay for protein-ligand interaction
蛋白质-配体相互作用的高通量测定
- 批准号:
8263370 - 财政年份:2011
- 资助金额:
$ 58.02万 - 项目类别:
Small molecule inhibitors of bacterial secretion system
细菌分泌系统小分子抑制剂
- 批准号:
7337974 - 财政年份:2007
- 资助金额:
$ 58.02万 - 项目类别:
相似海外基金
Mechanistic insights into multifaceted roles of coronavirus exoribonuclease complex
冠状病毒外核糖核酸酶复合物多方面作用的机制见解
- 批准号:
10713523 - 财政年份:2023
- 资助金额:
$ 58.02万 - 项目类别:
Novel Function(s) of Arenavirus NP Exoribonuclease
Arenavirus NP 核糖核酸外切酶的新功能
- 批准号:
10525101 - 财政年份:2022
- 资助金额:
$ 58.02万 - 项目类别:
Novel Function(s) of Arenavirus NP Exoribonuclease
Arenavirus NP 核糖核酸外切酶的新功能
- 批准号:
10624457 - 财政年份:2022
- 资助金额:
$ 58.02万 - 项目类别:
Characterizing the XRN1 exoribonuclease as a therapeutic target in non-small cell lung cancer
将 XRN1 核糖核酸外切酶表征为非小细胞肺癌的治疗靶点
- 批准号:
10215766 - 财政年份:2021
- 资助金额:
$ 58.02万 - 项目类别:
Exploring the Coronavirus Exoribonuclease as an Antiviral Target
探索冠状病毒外核糖核酸酶作为抗病毒靶点
- 批准号:
10238324 - 财政年份:2021
- 资助金额:
$ 58.02万 - 项目类别:
Characterizing the XRN1 exoribonuclease as a therapeutic target in non-small cell lung cancer
将 XRN1 核糖核酸外切酶表征为非小细胞肺癌的治疗靶点
- 批准号:
10656174 - 财政年份:2021
- 资助金额:
$ 58.02万 - 项目类别:
Characterizing the XRN1 exoribonuclease as a therapeutic target in non-small cell lung cancer
将 XRN1 核糖核酸外切酶表征为非小细胞肺癌的治疗靶点
- 批准号:
10370384 - 财政年份:2021
- 资助金额:
$ 58.02万 - 项目类别:
Exploiting the SARS-CoV-2 nsp14 3'-5'-exoribonuclease as a target for antiviral chemotherapy
利用 SARS-CoV-2 nsp14 3-5-核糖核酸外切酶作为抗病毒化疗的靶点
- 批准号:
MR/V036904/1 - 财政年份:2020
- 资助金额:
$ 58.02万 - 项目类别:
Research Grant
Dissecting the role of the coronavirus proofreading exoribonuclease in RNA recombination
剖析冠状病毒校对核糖核酸酶在 RNA 重组中的作用
- 批准号:
10268982 - 财政年份:2020
- 资助金额:
$ 58.02万 - 项目类别:
Flow responsive endothelial Pnpt1: an exoribonuclease that regulates mitochondrial function and vascular disease
流量响应内皮 Pnpt1:一种调节线粒体功能和血管疾病的核糖核酸外切酶
- 批准号:
9750410 - 财政年份:2018
- 资助金额:
$ 58.02万 - 项目类别: